The Long-Term Efficacy of Erythropoiesis-Stimulating Agents in Patients With Low-Risk or Intermediate-1-Risk Myelodysplastic Syndrome: Multicenter Real-Life Data.


Creative Commons License

Aslaner Ak M., Gedük A., Acar İ. H., Polat M. G., Sunu C., Bolaman A. Z., ...Daha Fazla

Turkish journal of haematology : official journal of Turkish Society of Haematology, cilt.40, ss.92-100, 2023 (SCI-Expanded) identifier identifier